triclosan has been researched along with Koch's Disease in 18 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the present paper, we report the synthesis via catalytic Michael reaction and biological results of a series of 3-heteryl substituted pyrrolidine-2,5-dione derivatives as moderate inhibitors against Mycobacterium tuberculosis H37Rv growth." | 7.80 | Synthesis of 3-heteryl substituted pyrrolidine-2,5-diones via catalytic Michael reaction and evaluation of their inhibitory activity against InhA and Mycobacterium tuberculosis. ( Baltas, M; Gorichko, M; Guidetti, B; Lherbet, C; Matviiuk, T; Mori, G; Pasca, MR; Rodriguez, F; Voitenko, Z, 2014) |
| "In the present paper, we report the synthesis via catalytic Michael reaction and biological results of a series of 3-heteryl substituted pyrrolidine-2,5-dione derivatives as moderate inhibitors against Mycobacterium tuberculosis H37Rv growth." | 3.80 | Synthesis of 3-heteryl substituted pyrrolidine-2,5-diones via catalytic Michael reaction and evaluation of their inhibitory activity against InhA and Mycobacterium tuberculosis. ( Baltas, M; Gorichko, M; Guidetti, B; Lherbet, C; Matviiuk, T; Mori, G; Pasca, MR; Rodriguez, F; Voitenko, Z, 2014) |
| "Triclosan is a widely used broad-spectrum biocidal agent." | 2.58 | Triclosan and its derivatives as antimycobacterial active agents. ( Krátký, M; Vinšová, J; Vosátka, R, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Telvekar, VN | 1 |
| Bairwa, VK | 1 |
| Satardekar, K | 1 |
| Bellubi, A | 1 |
| Matviiuk, T | 1 |
| Mori, G | 1 |
| Lherbet, C | 1 |
| Rodriguez, F | 1 |
| Pasca, MR | 1 |
| Gorichko, M | 1 |
| Guidetti, B | 1 |
| Voitenko, Z | 1 |
| Baltas, M | 1 |
| More, UA | 1 |
| Joshi, SD | 1 |
| Aminabhavi, TM | 1 |
| Gadad, AK | 1 |
| Nadagouda, MN | 1 |
| Kulkarni, VH | 1 |
| Vosátka, R | 1 |
| Krátký, M | 1 |
| Vinšová, J | 1 |
| Kini, SG | 1 |
| Bhat, A | 1 |
| Pan, Z | 1 |
| Dayan, FE | 1 |
| Topf, CM | 1 |
| Schiebel, J | 1 |
| Kisker, C | 1 |
| Holzgrabe, U | 1 |
| SAYE, L | 1 |
| SCHMITZ, F | 1 |
| LOHR, K | 1 |
| SEUSING, J | 1 |
| FREERKSEN, E | 1 |
| SZYBALSKI, W | 1 |
| RAMOS DIAZ, A | 1 |
| NASTA, M | 1 |
| ALGEORGE, G | 1 |
| ARHIRI, M | 1 |
| NEGULESCU, V | 1 |
| BERTHET, E | 1 |
| RABUKHIN, AE | 1 |
| SZASZ, E | 1 |
| BURSTENBINDER, R | 1 |
| BRUGGER, H | 1 |
2 reviews available for triclosan and Koch's Disease
| Article | Year |
|---|---|
Triclosan and its derivatives as antimycobacterial active agents.
Topics: Animals; Antitubercular Agents; Drug Resistance, Bacterial; Humans; Mycobacterium tuberculosis; Tric | 2018 |
[Old and new anti-mycobacterial drugs. Fatty acid synthesis as a target].
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase; Anti-Bacterial Agents; Antitubercular Agents; Fatty Acid | 2012 |
16 other studies available for triclosan and Koch's Disease
| Article | Year |
|---|---|
Novel 2-(2-(4-aryloxybenzylidene) hydrazinyl)benzothiazole derivatives as anti-tubercular agents.
Topics: Antitubercular Agents; Benzothiazoles; Chemistry, Pharmaceutical; Drug Design; Escherichia coli; Hum | 2012 |
Synthesis of 3-heteryl substituted pyrrolidine-2,5-diones via catalytic Michael reaction and evaluation of their inhibitory activity against InhA and Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Humans; Microbial Sensitivity Tests; Models, Molecular; M | 2014 |
Design, synthesis, molecular docking and 3D-QSAR studies of potent inhibitors of enoyl-acyl carrier protein reductase as potential antimycobacterial agents.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Design; Humans; Hydrazones; Ligands; Molecular Docki | 2014 |
Synthesis and antitubercular activity of heterocycle substituted diphenyl ether derivatives.
Topics: Antitubercular Agents; Drug Design; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enzyme Inhibitors | 2010 |
[Anatomic and clinical basis for therapeutic indications in tracheobronchopulmonary tuberculosis].
Topics: Humans; Triclosan; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Tuberculosis and military insurance; legal basis and activities].
Topics: Disease; Humans; Insurance; Military Personnel; Triclosan; Tuberculosis; Veterans | 1954 |
[The evaluation of activity of tuberculous pulmonary changes in various age on basis of roentgenological findings].
Topics: Aging; Humans; Radiography; Triclosan; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Basis, possibilities and limitations of chemotherapy in tuberculosis].
Topics: Humans; Mycobacterium tuberculosis; Triclosan; Tuberculosis | 1955 |
Theoretical basis of multiple chemotherapy.
Topics: Humans; Triclosan; Tuberculosis | 1956 |
[Biological resistance as fundamental basis in a new plan of treatment of ambulatory pulmonary tuberculosis].
Topics: Humans; Patient Care Planning; Triclosan; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Experimental basis for the chemioprophylaxis of tuberculosis].
Topics: Antibiotic Prophylaxis; Humans; Triclosan; Tuberculosis | 1960 |
[Basis of organization of the campaign against tuberculosis in countries with large tuberculous endemia].
Topics: Antibiotic Prophylaxis; Organizations; Triclosan; Tuberculosis | 1959 |
[Prophylaxsis-the basis of tuberculosis control].
Topics: Antibiotic Prophylaxis; Humans; Triclosan; Tuberculosis | 1960 |
Phthisiogenesis; an attempt to classify chronic pulmonary tuberculosis of adults on a genetic basis.
Topics: Adult; Genetic Therapy; Humans; Triclosan; Tuberculosis; Tuberculosis, Pulmonary | 1950 |
[Theoretical basis for the tuberculosis diet].
Topics: Diet; Diet Therapy; Humans; Triclosan; Tuberculosis; Tuberculosis, Pulmonary | 1951 |
[Anatomical basis of extensive benign opacity of the lung in primary tuberculosis of children].
Topics: Child; Humans; Lung; Triclosan; Tuberculosis; Tuberculosis, Pulmonary | 1950 |